Cell-mediated immunity in breast cancer patients

Biomedicine and Pharmacotherapy

Volumn 50, Issue 8, 1996, Pages 337-342

  Nicolini, A ^a,b   Ferrari, P ^a   Spinelli, R ^a   Carpi, A ^a   Sagripanti, A ^a   Ambrogi, F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Breast cancer; Immunosuppression; Relapse

Indexed keywords

B LYMPHOCYTE; BREAST CANCER; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MAJOR CLINICAL STUDY; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029848643     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(96)89665-X     Document Type: Conference Paper

References (2)

1. American Joint Committee on Cancer Staging and End-Results Reporting. In: Beahrs OH, Myers MA, eds. Manual for Staging of Cancer. Second Edition. Philadelphia: Lippincott, 1983;127-133
2. Bernengo MG, Doveil GC, Appino A, Massobrio R. Thymus hormones in malignant melanoma: personal experiences with thymostimulin (TP-1) and thymopentin (TP-5). In: Nagel G, Schioppacassi G, Schuff-Werner P, eds. Thymus Hormones in Oncology. Rome: Sedac srl, 1988;133-48